Back

Efficacy and limitations of quinidine therapy in patients with Brugada Syndrome

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Anti-arrhythmic drug therapy: new concepts on old drugs Antiarrhythmic Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Andrea Mazzanti

University of Pavia, Pavia (Italy)

3 More presentations in this session

Presentation thumbnail
State of the Art from history to future of anti-arrhythmic drugs
Professor J. Camm (London, GB)
Slides Video
Presentation thumbnail
A prospective, multicenter, nationwide, observational study of flecainide controlled release on the quality of life of patients with atrial fibrillation in Greece, the REFLEC-CR study
Doctor S. Tzeis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation
Doctor M. Mihajlovic (Belgrade, RS)
Abstract Slides Video

Access the full session

Session thumbnail
Anti-arrhythmic drug therapy: new concepts on old drugs

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)
thumbnail
Congress Presentation
Interactions of AAD with particular patient profiles, other medications and CIEDs : what is the most important to know?
thumbnail
Congress Presentation
The most fear: how to avoid and manage proarrhythmia and toxicity?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources